These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents. Abdel-Rahman SM, Jacobs RF, Massarella J, Kauffman RE, Bradley JS, Kimko HC, Kearns GL, Shalayda K, Curtin C, Maldonado SD, Blumer JL. Antimicrob Agents Chemother; 2007 Aug; 51(8):2668-73. PubMed ID: 17517842 [Abstract] [Full Text] [Related]
4. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection. Zhou H, Goldman M, Wu J, Woestenborghs R, Hassell AE, Lee P, Baruch A, Pesco-Koplowitz L, Borum J, Wheat LJ. J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843 [Abstract] [Full Text] [Related]
5. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis. Groll AH, Wood L, Roden M, Mickiene D, Chiou CC, Townley E, Dad L, Piscitelli SC, Walsh TJ. Antimicrob Agents Chemother; 2002 Aug; 46(8):2554-63. PubMed ID: 12121932 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection. Zhao Q, Zhou H, Pesco-Koplowitz L. J Clin Pharmacol; 2001 Dec; 41(12):1319-28. PubMed ID: 11762559 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of itraconazole in diabetic rats. Lee U, Choi YH, Kim SH, Lee BK. Antimicrob Agents Chemother; 2010 Feb; 54(2):931-3. PubMed ID: 19995926 [Abstract] [Full Text] [Related]
10. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers. Barone JA, Moskovitz BL, Guarnieri J, Hassell AE, Colaizzi JL, Bierman RH, Jessen L. Pharmacotherapy; 1998 Feb; 18(2):295-301. PubMed ID: 9545149 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation. Mouton JW, van Peer A, de Beule K, Van Vliet A, Donnelly JP, Soons PA. Antimicrob Agents Chemother; 2006 Dec; 50(12):4096-102. PubMed ID: 16982783 [Abstract] [Full Text] [Related]
16. Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients. Koks CH, Sparidans RW, Lucassen G, Crommentuyn KM, Beijnen JH. J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb 05; 767(1):103-10. PubMed ID: 11865826 [Abstract] [Full Text] [Related]
18. Effect of omeprazole on the pharmacokinetics of itraconazole. Jaruratanasirikul S, Sriwiriyajan S. Eur J Clin Pharmacol; 1998 Apr 05; 54(2):159-61. PubMed ID: 9626921 [Abstract] [Full Text] [Related]
19. Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons. Koks CH, Huitema AD, Kroon ED, Chuenyam T, Sparidans RW, Lange JM, Beijnen JH. Ther Drug Monit; 2003 Apr 05; 25(2):229-33. PubMed ID: 12657919 [Abstract] [Full Text] [Related]
20. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia. Prentice AG, Warnock DW, Johnson SA, Taylor PC, Oliver DA. J Antimicrob Chemother; 1995 Oct 05; 36(4):657-63. PubMed ID: 8591940 [Abstract] [Full Text] [Related] Page: [Next] [New Search]